- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1720-8386
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Correction to: Thyrotropin receptor antibodies and Graves’ orbitopathy ; day:24 ; month:7 ; year:2021 ; pages:1
Journal of endocrinological investigation ; (24.7.2021), 1
- Urheber
-
Diana, T.
Ponto, K. A.
Kahaly, G. J.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40618-021-01632-2
- URN
-
urn:nbn:de:101:1-2021102403023199919726
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:23 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Diana, T.
- Ponto, K. A.
- Kahaly, G. J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Thyrotropin Receptor Blocking Antibodies
Comparison of three methods for determining anti-thyrotropin receptor antibodies (TRAb) for diagnosis of Graves’ disease: a clinical validation
Thyrotropin
Prevalence of Thyrotropin Receptor Antibodies and Clinical Profile of Patients with Alopecia Areata: A Cross-Sectional Study
Thyrotropin-Ampullen
Molecular basis for the activation of thyrotropin-releasing hormone receptor
Thyrotropin-producing pituitary adenoma simultaneously existing with Graves’ disease: a case report
Amniotic fluid thyrotropin (TSH) following maternal administration of thyrotropin releasing hormone
Graves’ Disease Mechanisms: The Role of Stimulating, Blocking, and Cleavage Region TSH Receptor Antibodies
Author Correction: Structural insights into thyrotropin-releasing hormone receptor activation by an endogenous peptide agonist or its orally administered analogue
Comparison Between Thyroid Stimulating Immunoglobulin and TSH-Receptor Antibodies in the Management of Graves’ Orbitopathy
Der überschiessende Thyrotropin-Releasing-Hormon-Test
Thyrotropin Receptor Blocking Antibodies
Comparison of three methods for determining anti-thyrotropin receptor antibodies (TRAb) for diagnosis of Graves’ disease: a clinical validation
Thyrotropin
Prevalence of Thyrotropin Receptor Antibodies and Clinical Profile of Patients with Alopecia Areata: A Cross-Sectional Study
Thyrotropin-Ampullen
Molecular basis for the activation of thyrotropin-releasing hormone receptor
Thyrotropin-producing pituitary adenoma simultaneously existing with Graves’ disease: a case report
Amniotic fluid thyrotropin (TSH) following maternal administration of thyrotropin releasing hormone
Graves’ Disease Mechanisms: The Role of Stimulating, Blocking, and Cleavage Region TSH Receptor Antibodies
Author Correction: Structural insights into thyrotropin-releasing hormone receptor activation by an endogenous peptide agonist or its orally administered analogue
Comparison Between Thyroid Stimulating Immunoglobulin and TSH-Receptor Antibodies in the Management of Graves’ Orbitopathy
Der überschiessende Thyrotropin-Releasing-Hormon-Test
Thyrotropin Receptor Blocking Antibodies
Comparison of three methods for determining anti-thyrotropin receptor antibodies (TRAb) for diagnosis of Graves’ disease: a clinical validation
Thyrotropin
Prevalence of Thyrotropin Receptor Antibodies and Clinical Profile of Patients with Alopecia Areata: A Cross-Sectional Study
Thyrotropin-Ampullen
Molecular basis for the activation of thyrotropin-releasing hormone receptor
Thyrotropin-producing pituitary adenoma simultaneously existing with Graves’ disease: a case report
Amniotic fluid thyrotropin (TSH) following maternal administration of thyrotropin releasing hormone
Graves’ Disease Mechanisms: The Role of Stimulating, Blocking, and Cleavage Region TSH Receptor Antibodies
Author Correction: Structural insights into thyrotropin-releasing hormone receptor activation by an endogenous peptide agonist or its orally administered analogue
Comparison Between Thyroid Stimulating Immunoglobulin and TSH-Receptor Antibodies in the Management of Graves’ Orbitopathy